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Allergic bronchial asthma has become a major 
public  health  burden  in  industrialized  coun-
tries, and the incidence of this chronic inflam-
matory disease has been steadily growing over 
the last decades. Although many susceptibil-
ity genes have been identified (Moffatt et al., 
2007;  Vercelli,  2008),  genetics  alone  cannot 
explain  the  velocity  of  these  changes.  Ad-
ditional factors must have contributed to the 
growing  incidence  of  asthma.  In  agreement 
with the hygiene hypothesis, epidemiological 
studies indicate that lack of early childhood ex-
posure to microbial agents may contribute to 
increased susceptibility to the development of 
allergic  diseases  (Strachan,  2000).  Moreover, 
environments characterized by a diverse and 
concentrated microbial milieu, such as tradi-
tional farming sites, may protect from allergic 
diseases  (Riedler  et  al.,  2001;  Majkowska-
Wojciechowska et al., 2007; Midodzi et al., 
2007; von Mutius and Radon, 2008). In this 
regard, analysis of cowshed dust samples has 
identified the Gram-negative, nonpathogenic 
bacterium Acinetobacter lwoffii F78 as a potential 
allergo-protective agent (Korthals et al., 2008). 
Although experimental approaches using a mouse 
model of acute allergic airway inflammation 
suggest a strong allergy protective potential of 
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The pre- and postnatal environment may represent a window of opportunity for allergy and 
asthma prevention, and the hygiene hypothesis implies that microbial agents may play an 
important role in this regard. Using the cowshed-derived bacterium Acinetobacter lwoffii 
F78 together with a mouse model of experimental allergic airway inflammation, this study 
investigated the hygiene hypothesis, maternal (prenatal) microbial exposure, and the in-
volvement of Toll-like receptor (TLR) signaling in prenatal protection from asthma. Maternal 
intranasal exposure to A. lwoffii F78 protected against the development of experimental 
asthma in the progeny. Maternally, A. lwoffii F78 exposure resulted in a transient increase in 
lung and serum proinflammatory cytokine production and up-regulation of lung TLR messen-
ger RNA. Conversely, suppression of TLRs was observed in placental tissue. To investigate 
further, the functional relevance of maternal TLR signaling was tested in TLR2/3/4/7/9/ 
knockout mice. The asthma-preventive effect was completely abolished in heterozygous 
offspring from A. lwoffii F78–treated TLR2/3/4/7/9/ homozygous mother mice. Further-
more, the mild local and systemic inflammatory response was also absent in these A. lwoffii 
F78–exposed mothers. These data establish a direct relationship between maternal bacterial 
exposures, functional maternal TLR signaling, and asthma protection in the progeny.
© 2009 Conrad et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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(MCh) required to induce a 50% decrease in lung function 
compared with a negative control, demonstrated that prenatal 
treatment with A. lwoffii F78 resulted in normalization of air-
way reactivity (Fig. 1 D).
An examination of OVA-specific antibody titers in OVA-
sensitized and -challenged offspring revealed a trend toward 
decreased Th2 antibody titers in mice prenatally treated with 
A. lwoffii F78 (OVA-specific IgE = 155 ± 60.54 ng/ml vs. 
72.64 ± 9.202 ng/ml, and OVA-specific IgG1 = 7,076 ± 
920.7 ng/ml vs. 5,088 ± 924.6 ng/ml; prenatal PBS control 
vs. prenatal A. lwoffii F78, respectively), but these differences 
did not reach statistical significance. Several possible reasons 
may explain this finding. Offspring were sensitized using the 
adjuvant aluminum hydroxide, which is known to elicit a 
very strong Th2 response (Brewer et al., 1999) and specifi-
cally affect antibody titers (Conrad et al., 2009). Although 
prenatal A. lwoffii F78 treatment appears to positively influ-
ence antibody titers, its effect may not be strong enough to 
override the effects of the adjuvant used. Additionally, it is 
also possible that the protection produced by prenatal A. lwof-
fii F78 treatment occurs in a B cell–independent manner. If 
this was the case, it would indicate that treatment does not 
prevent sensitization per se but rather initiates mechanisms 
that prevent or dampen the elicitation of the inflammatory 
response to allergen challenge.
A. lwoffii F78 is not the only type of bacteria that can 
engender protective effects through prenatal treatment. Pre-
vious  experiments  revealed  that  prenatal  treatment  with 
both Lactobacillus rhamnosus GG (Blümer et al., 2007) and 
the Gram-negative cell-wall component LPS (Blümer et al., 
2005) also had a protective effect on the development of 
experimental asthma in the next generation. The strongest 
effect, however, was observed using A. lwoffii F78, because 
treatment with A. lwoffii F78 prevented the development of 
airway hyperresponsiveness together with a prevention of 
allergic  airway  inflammation.  Therefore,  we  selected  A. 
lwoffii  F78  to  further  explore  underlying  mechanisms  in 
terms of innate and adaptive immune responses. Because 
Gram-positive and -negative microbes differ significantly in 
terms of usage of PRRs, it is very likely that the mechanism 
of asthma protection depends on the type of microbe or 
microbial compounds used. In the current study, we have 
elucidated a novel mechanism for asthma protection by a Gram-
negative bacterium. Further studies are necessary to investigate 
cellular and molecular pathways underlying asthma protec-
tion in other model situations.
Using A. lwoffii F78, a Gram-negative bacterium iso-
lated from the stable dusts of traditional farms, and a mouse 
model of experimental asthma, our data demonstrate a di-
rect cause–effect relationship between maternal (prenatal) 
exposure to farm-related bacteria and protection from al-
lergic airway inflammation in the progeny. Because only 
mother mice were directly exposed to A. lwoffii F78, the 
reduced asthma phenotype observed in the progeny must 
have resulted from a transfer of protective effects from the 
mother to the fetus.
this bacterial strain (Debarry et al., 2007), nothing is known 
about the effects of prenatal exposure to A. lwoffii F78 and 
possible downstream mechanisms affecting allergic inflamma-
tory responses in the progeny.
Respiratory  allergies,  including  bronchial  asthma,  are 
chronic inflammatory diseases that are based on a complex 
deregulated  interaction  of  both  innate  and  adaptive  im-
mune responses (Hammad and Lambrecht, 2008; Holgate 
and Polosa, 2008). Regarding the maturation of the adap-
tive immune system, it is now well established that the de-
velopment of functionally active T cell subsets starts already 
prenatally (Warner et al., 2000), and it has been proposed 
that immunoprogramming by environmental influences may 
occur at this early developmental stage. Indeed, studies have 
demonstrated that many factors affecting the initiation and 
course of respiratory allergies appear to act within a narrow 
window of opportunity, either prenatally and/or early in life 
(Ege et al., 2006; Rowe et al., 2007). It is still unresolved, 
however, how protective signals are transferred from the 
mother to the developing fetus.
Regarding mechanisms by which A. lwoffii F78 may ex-
ert its protective effects, consideration must be given to in-
nate immune processes that participate in initial microbial 
recognition. Innate immunity functions as a first line of de-
fense that uses, in addition to physical barriers, a pattern rec-
ognition receptor (PRR) system that can identify a broad 
spectrum  of  microbial  components.  Toll-like  receptors 
(TLRs) are a major class of PRRs expressed by several cell 
types, including epithelium and immune cells, that play a vi-
tal role in the initiation of the immune response (Gon, 2008; 
Kawai and Akira, 2009).
Combining prenatal exposure to the cowshed bacte-
rium A. lwoffii F78 with a mouse model of allergic airway 
inflammation, we show in this report that prenatal exposure 
to farming-related microbes protects from the development 
of allergic phenotypes in the next generation. The process 
by which this protection is achieved involves a low level, 
local, and systemic maternal innate immune response, and 
the transference of protective immunity from the mother to 
the fetus is fully dependent on the action of the maternal 
TLR2, 3, 4, 7, and/or 9.
RESULTS AND DISCUSSION
Prenatal A. lwoffii F78 application protects  
against experimental asthma pathology in adult offspring
As shown in Fig. 1, the development of experimental asthma 
was largely prevented in OVA-sensitized and -challenged 
offspring from A. lwoffii F78–exposed mothers. This was exhib-
ited by a significantly lower influx of eosinophils and lympho-
cytes into the airway lumen as compared with OVA-sensitized 
and -challenged offspring from sham-exposed control mothers 
(Fig. 1 A). In accordance, histological analyses of tissue in-
flammation revealed a significantly reduced degree of airway 
inflammation with fewer mucus-producing goblet cells (Fig. 1, 
B and C). Lung provocation tests, in which airway hyper-
reactivity is defined as a lower concentration of -methacholine JEM VOL. 206, December 21, 2009  2871
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were created by intercrossing respective single TLR knock-
out mice. The TLR2/3/4/7/9/ mouse was best suited to 
the experimental design because, as a result of heterodimer 
formation, knockout of TLR2 also functionally eliminates 
TLR1 and 6 function. This leaves only TLR5, which is unlikely 
to be involved in A. lwoffii F78 recognition. TLR2/3/4/7/9/ 
mice were healthy, bred normally under regular specific 
pathogen-free conditions, and were fully responsive toward 
challenge with cytokines and unrelated pathogen-associated 
molecular patterns.
To demonstrate the principal functionality of the TLR 
signaling system in TLR2/3/4/7/9/ knockout mice, BM-
derived macrophages (BMDMs) from homozygous, het-
erozygous, and wild-type animals were tested in vitro for 
responsiveness to TLR agonists and A. lwoffii F78 specifi-
cally (Fig. 2). As expected, BMDMs from TLR2/3/4/7/9/ 
animals generated no response to TLR agonists or A. lwoffii 
Generation of a quintuple TLR2/3/4/7/9/ knockout mouse
After demonstrating the protective effects of prenatal A. lwof-
fii F78 treatment, subsequent investigations sought to com-
pare  the  action  of  A.  lwoffii  F78  in  a  system  where  its 
recognition is abolished (or greatly reduced) in the mother. 
Because the recognition of A. lwoffii F78 is likely very com-
plex and it is conceivable that the TLR family plays a large 
role in maternal A. lwoffii F78 recognition, we designed an 
experimental system in which the recognition of a broad 
spectrum of pathogen-associated molecular patterns was 
selectively impaired in the mother. Because MyD88/ or 
MYD88//TRIF/ mice lack not only TLR activity but 
are also deficient in IL-1 cytokine family member signaling, 
which plays a role in the regulation of inflammatory responses, 
we considered these mice unsuitable for our experimental 
approach. Instead, TLR2/, TLR3/, TLR4/, TLR7/, 
and TLR9/ quintuple knockout mice (TLR2/3/4/7/9/) 
Figure 1.  Prenatal A. lwoffii F78 exposure significantly prevented the extent of the asthmatic phenotype in the offspring. White bars repre-
sent offspring exposed prenatally to control PBS, and black bars represent offspring exposed prenatally to A. lwoffii F78. (A) Differential leukocyte num-
bers in the BAL of offspring. (B) Representative lung tissue cross sections stained with PAS to visualize mucus-producing goblet cells (arrows) and airway 
inflammation in offspring. Bars, 100 µm. (C) Quantification of mucus-producing goblet cells, mucus volume, and inflammation in offspring airways. (D) 
Offspring airway responsiveness to MCh. Results represent one out of two independently performed experiments with similar outcomes (n ≥ 8 per group). 
Means ± SEM are shown. *, P < 0.05; **, P < 0.01; ***, P < 0.001.2872 Prenatal microbial exposure, TLR, and asthma | Conrad et al.
bly induced by TLR-mediated activation of airway epithelial 
cells or locally residing innate immune cells such as macro-
phages (Medzhitov, 2007). Notably, acute and chronic expo-
sure to A. lwoffii F78 was well tolerated by treated animals. 
After intranasal microbial application, mice exhibited normal 
behavior and, throughout the study, did not show signs of 
weight loss or lethargy. As demonstrated previously, chronic 
treatment with the nonpathogenic A. lwoffii F78 did not re-
sult in infection, as histological lung sections from chronically 
treated mice showed no signs of inflammation and the lung 
tissues were cleared of the bacteria (Debarry et al., 2007).
To analyze the immune response generated in mother 
mice by intranasal A. lwoffii F78 treatment in the absence of 
major microbial sensors such as TLRs, TLR2/3/4/7/9/ 
mice were treated a single time with A. lwoffii F78. Analysis 
of BAL cell counts, as well as BAL and serum cytokines, re-
vealed that in the absence of specific TLRs, animals mount 
none of the responses observed in wild-type mice, suggesting 
that the initiation of innate immune responses to A. lwoffii 
F78 is fully dependent on TLR function (unpublished data).
Application of A. lwoffii F78 alters maternal TLR  
expression patterns
Maternal treatment with A. lwoffii F78 resulted in modulation 
of lung TLR mRNA expression. Examination of lung-tissue 
TLR mRNAs after acute A. lwoffii F78 application revealed 
an up-regulation of TLR2, 3, 6, 7, and 9 expression. (Fig. 4 A). 
Although changes in TLR mRNA expression occurred at 
varying time points for different receptors, all aforementioned 
F78, whereas BMDMs from heterozygous animals reacted 
similarly to the different stimuli as wild-type mice.
Application of A. lwoffii F78 induces maternal local  
and systemic innate immune responses
As a first step in investigating the mechanism by which mater-
nal A. lwoffii F78 treatment confers protection against experi-
mental  asthma  in  progeny,  a  kinetic  was  performed  to 
determine the immediate local effects of intranasal A. lwoffii 
F78 administration. Acutely (analysis at 1, 4, 24, or 48 h after 
application of a single dose) and chronically (treated three times 
per week for five consecutive weeks) exposed mice equivalent 
in age to the breeding mothers were examined. After a single 
intranasal A. lwoffii F78 application, a fast and transient inflam-
matory response was observed within the airways. This response 
was primarily characterized by an increase of inflammatory cyto-
kines in the bronchoalveolar lavage (BAL) fluid that peaked 
at different time points: TNF after 1 h, IL-6 after 4 h, and 
IL-12p40 after 24 h (Fig. 3 B). Additionally, an influx of neutro-
phils and lymphocytes into the BAL fluid was observed, with 
the maximum after 24 and 48 h, respectively (Fig. 3 A). In se-
rum, IL-6 levels peaked after 4 h (Fig. 3 C).
In contrast to the single-dose response, the maternal air-
ways showed partial adaptation to chronic A. lwoffii F78 ex-
posure,  as  neutrophils  and  lymphocytes  were  no  longer 
detectable after 5 wk of treatment (Fig. 3 D). However, TNF, 
IL-6, and IL-12p40 levels still remained increased in BAL 
fluids (Fig. 3 E). These data indicate that chronic exposure 
leads to a weak but persistent innate immune response possi-
Figure 2.  Heterozygous TLR2/3/4/7/9+/ mice respond similarly to TLR agonists as wild-type mice. Macrophages prepared from BM cells of 
wild-type, heterozygous, and homozygous TLR2/3/4/7/9/ mice were in vitro stimulated with specific TLR agonists or A. lwoffii F78, as indicated. 
Pam2CSK4, Poly I:C, LPS, R848, and CpG specifically stimulate TLR2, 3, 4, 7, and 9, respectively. Results are from one experiment performed in duplicate 
(n = 2 per group). Means ± SEM are shown. X, not detectable.JEM VOL. 206, December 21, 2009  2873
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regulation of placental TLR mRNA expression was paralleled 
by a significant suppression of the placental proinflammatory 
mediators IL-1 and TNF (Fig. 4 C). A similar effect was ob-
served in terms of T cell effector responses on the level of IL-4 
(Th2), IFN- (Th1), and IL-10 (T reg) mRNA levels.
To further study the effects of maternal TLRs on placental 
mRNA expression, TLR and cytokine mRNA from the pla-
centas of sham- or A. lwoffii F78–treated TLR2/3/4/7/9/ ho-
mozygous knockout mother mice carrying TLR2/3/4/7/9+/ 
heterozygous offspring were examined. These experiments 
revealed that in the absence of maternal TLRs, fetal placentas 
exhibit a different TLR mRNA expression pattern than that 
of the whole placenta (Fig. 4 B). These results indicate that 
the TLR mRNA down-regulation seen in wild-type A. lwoffii 
TLRs were up-regulated at the 4-h time point. Further ex-
amination of maternal lung TLR expression after chronic ex-
posure  to  A.  lwoffii  F78  revealed  similar  TLR  expression 
patterns, with the exception of TLR3 and 9, which appear to 
have attenuated expression after chronic exposure (Fig. 4 A). 
Interestingly, TLR4 mRNA expression remained unchanged 
throughout the entire observation period.
Up-regulation of TLR mRNA in the maternal lung was 
accompanied by TLR down-regulation in the placenta. Ex-
amination of placentas from A. lwoffii F78–treated mother 
mice showed a significant down-regulation of TLR6 and 7 
mRNA (compared with sham-treated controls), accompa-
nied by a nonsignificant trend toward lower mRNA levels in 
all other TLRs tested (Fig. 4 B). Furthermore, the down-
Figure 3.  Single or chronic A. lwoffii F78 exposure induces local and systemic innate immune responses. All animals used were age equivalent 
to breeding mothers. White bars represent PBS control exposure, and black bars represent A. lwoffii F78 exposure. (A–C) Single-exposure kinetic. Results 
represent one out of two independently performed experiments with similar outcomes (n ≥ 7 per group). (A) Differential leukocyte numbers in the BAL. 
(B) Local concentration of proinflammatory cytokines in BAL fluid. (C) Serum IL-6 concentration. (D and E) Chronic exposure three times per week for  
5 wk. Results represent one out of two independently performed experiments with similar outcomes (n = 4 per group). (D) Differential leukocyte numbers 
in BAL. (E) Local concentration of proinflammatory cytokines in BAL fluid after chronic exposure to A. lwoffii F78. Means ± SEM are shown. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001. nd, not detectable.2874 Prenatal microbial exposure, TLR, and asthma | Conrad et al.
F78–treated animals may occur mainly on the maternal side of 
the placenta. Quantitative real-time PCR analysis of placental 
cytokine mRNAs revealed that in the absence of maternal 
TLRs, there is no longer a difference in placental cytokine 
production between PBS- and A. lwoffii F78–treated groups 
(Fig. 4 C). This further supports the hypothesis that maternal 
TLRs are required for the transfer of protective antiallergic 
effects to the fetus.
To investigate how signals generated by intranasal A. lwoffii 
F78 treatment might be transferred from the maternal lung to 
the placenta (feto–maternal interface), subsequent experiments 
were designed to examine the effect of serum IL-6 (generated 
by A. lwoffii F78 exposure) on placental tissue. In vitro primary 
placental culture revealed that incubation with IL-6 resulted in 
an alteration of placental TLR mRNA expression; TLR4 and 
9 were significantly down-regulated upon exposure to IL-6, 
with TLR2, 6, and 7 following a similar trend (Fig. 4 D). The 
local transient proinflammatory response to A. lwoffii F78 in 
the maternal airways was accompanied by counterregulatory 
activities in the placental tissue, indicating (a) a systemic distri-
bution of signals such as IL-6 after local bacterial exposure and 
(b) the generation of a tissue-specific response in the placenta.
Absence of endotoxin in amniotic fluid
It has been previously demonstrated that some environmental 
components that are able to pass the feto–maternal interface, 
via the amniotic membrane and swallowing of amniotic fluid, 
may directly activate the developing fetal immune system 
(Harju et al., 2005). It is also known that the presence of bac-
terial compounds, such as endotoxin in the placental com-
partment, may result in the abortion of the fetus (Entrican, 
2002). To rule out the possibility of microbial component 
transfer between mother and fetus, maternal fluids were tested 
for the presence of endotoxin derived from A. lwoffii F78 ex-
posure. In both maternal blood plasma and amniotic fluid, no 
differences were found in endotoxin levels between control 
and A. lwoffii F78–treated mothers (unpublished data).
In addition to measuring endotoxin levels in the maternal 
fluids, an experiment was designed to measure endotoxin-
induced  inflammatory  cytokine  expression  in  fetal  tissue 
from TLR2/3/4/7/9/ mothers mated to wild-type males. 
In this particular case, the mother will not respond to A. lwoffii 
F78, but if bacterial components such as endotoxin are made 
locally available to the heterozygous fetus, an inflammatory 
response should be detected in the fetal tissue. Comparison 
of inflammatory cytokine mRNA (TNF, IL-1, and IL-6) in 
Figure 4.  Maternal treatment with A. lwoffii F78 modulates ex-
pression of immune-relevant genes in lung and placental tissue. Bars 
represent the relative change in mRNA expression in the treated compared 
with the control group. All mRNA expression levels were calculated by set-
ting the mRNA expression of the control group as 100% and individually 
calculating the  expression for each mRNA sample. The calculated change 
in mRNA expression for each noncontrol individual was then plotted, and 
the mean and SEM calculated. (A) TLR mRNA expression in the wild-type 
maternal lung 4 h after intranasal A. lwoffii F78 exposure for both a single 
acute exposure and a 5-wk chronic exposure. (B) TLR mRNA expression in 
placentas from both wild-type and TLR2/3/4/7/9/ mice on day 18 of 
gestation. (C) Cytokine mRNA expression in placentas from both wild-type 
and TLR2/3/4/7/9/ mice on day 18 of gestation. (D) TLR mRNA expression 
from wild-type primary placental cell culture incubated with IL-6. In vivo 
results are from two independently performed experiments with similar 
outcomes (n ≥ 5 animals per group with two placentas per animal). In vitro 
results are from one experiment performed in triplicate (n = 3 per group). 
Means ± SEM are shown. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 for the 
treated group compared with control. @, P < 0.05; @@, P < 0.01; and 
@@@, P < 0.001 for acute versus chronic treatment. nd, not detectable.
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mice, treated with A. lwoffii F78 or control PBS, were mated 
with wild-type males to generate heterozygous offspring that 
have a fully functional TLR response (Fig. 2). At 4 wk of age, 
experimental asthma was induced in these offspring. Func-
tional knockout of the five TLRs in the mothers resulted in a 
loss of the A. lwoffii F78 asthma-protective effect in the off-
spring, as demonstrated by fully developed airway inflammation, 
goblet cell metaplasia, and mucus production in these animals 
(Figs. 5, A–C). Mice of the C57BL/6 background by them-
selves develop less hyperreactivity of the airways (Whitehead 
et al., 2003). Nonetheless, a significant improvement in 
lung function could be detected in sensitized offspring from 
A. lwoffii F78–exposed wild-type mothers, whereas heterozy-
gous offspring of TLR-dysfunctional mothers did not show 
normalization after prenatal bacterial treatment (Fig. 5 D).
the fetal tissue from sham- or A. lwoffii F78–treated mothers 
revealed no differences in mRNA expression (unpublished 
data). These results provide strong evidence that the fetus is 
not exposed to A. lwoffii F78–derived endotoxin from mater-
nal treatment. Finally, observation of the experimental asthma 
phenotype in heterozygous offspring from A. lwoffii F78–
treated TLR2/3/4/7/9/ mothers (discussed in detail in 
the next section) demonstrates that even if small quantities of 
endotoxin are made available to the developing fetus, it has 
no measurable phenotypic effect.
Protective effects of prenatal A. lwoffii F78 exposure 
require functional maternal TLR expression
To analyze the requirement of maternal TLR signaling for 
prenatal allergo-protection, female TLR2/3/4/7/9/ mother 
Figure 5.  Asthma-protective effects of prenatal A. lwoffii F78 treatment are dependent on maternal TLRs. White bars represent offspring 
exposed prenatally to control PBS, and black bars represent offspring exposed prenatally to A. lwoffii F78. All offspring were sensitized and challenged 
with OVA. (A) Differential leukocyte numbers in the BAL of offspring. (B) Representative lung tissue cross sections stained with PAS to visualize mucus-
producing goblet cells (arrows) and airway inflammation in offspring. Bars, 200 µm. (C) Quantification of mucus-producing goblet cells, mucus volume, 
and inflammation in offspring. (D) Offspring airway responsiveness to MCh. Results represent two individually performed experiments (WT mother–PBS, 
n = 13 OVA-treated offspring; WT mother–A. lwoffii F78, n = 11 OVA-treated offspring; TLR KO mother–PBS, n = 10 OVA-treated offspring; and TLR KO 
mother–PBS A. lwoffii F78, n = 16 OVA-treated offspring). Means ± SEM are shown. *, P < 0.05; ***, P < 0.001.2876 Prenatal microbial exposure, TLR, and asthma | Conrad et al.
BAL and differential cell counts. Offspring from A. lwoffii F78– or control-
treated mother mice were sacrificed 48 h after the last challenge. Using a 
tracheal cannula, BAL was performed one time using 1 ml PBS containing 
1× protease inhibitor cocktail (Roche). Total leukocytes were counted with 
an automated cell counter (Casy TT; Schaerfe Systems), and cell-free super-
natant was stored at –20°C for cytokine measurement. Cytospin prepara-
tions  were  stained  with  Diff-Quick  (Merz  &  Dade AG),  and  standard 
morphological  criteria  were  used  to  identify  cell  types.  100  cells  were 
counted per cytospin.
Measurement of offspring serum antibodies. Blood samples were taken 
from the axillary vessels, and serum levels of anti-OVA IgE and OVA IgG1 
were measured by ELISA as previously described (Blümer et al., 2007).
Measurement of cytokines. Cell-free supernatants from BAL fluids, cell-
culture supernatants, and blood serum were analyzed for IL-5, IL-6, IL-10, 
IL-12p40, IFN-, (Opteia Kit; BD), and TNF (Invitrogen) using ELISA tech-
nology as described by the manufacturers. Serum samples were diluted 1:5 
before measurement. Detection limits were 10 pg/ml for IL-4, IL-5, and 
TNF, 5 pg/ml for IFN-, and 4 pg/ml for IL-6 and IL12-p40, respectively.
Histology and quantitative morphological analysis of mucin in off-
spring airways. Directly after BAL, lungs were fixed with 10% formalin via 
the trachea, removed, and stored in 10% formalin. Lung tissues were embed-
ded into paraffin, and 3-µm sections were stained with periodic acid-Schiff 
(PAS). Goblet cell metaplasia and the volume of epithelial mucin (V mucin) 
per surface area of airway epithelial basal membrane (Sbm; as shown in the 
figures) were determined by means of point and intersection counting using 
the computer-assisted stereology tool box (CAST-Grid 2.0; Olympus; Sel et al., 
2008). The inflammatory score was quantified as follows: 0, normal; 1, few 
inflammatory cells; 2, one to two cell layer ring of inflammatory cells; and 3, 
three or more cell layer ring of inflammatory cells.
Quantitative analysis of mRNA expression in maternal lung, pla-
cental, and fetal tissue. Total RNA was extracted from the lung tissue of 
wild-type or TLR2/3/4/7/9/ mice intranasally exposed to A. lwoffii F78 
or control PBS either acutely (once) or chronically (treatment three times   
per week for 5 wk), as well as from placental and fetal torso tissue from gesta-
tion day 18 of chronically exposed mice. Acute and chronically exposed mice 
were age matched to the breeding mothers. Total RNA was then reverse 
transcribed (Omniscript RT Kit; QIAGEN) using oligo (dT) primers. A Ro-
torGene (Corbett) and the QuantiTect SYBR Green PCR Kit (QIAGEN) 
were used for quantitative real-time PCR of TLRs, IL-1, IL-6, TNF, IL-
12p35,  IL-12p40,  IL-4,  IFN-,  IL-10,  and  L32  (housekeeping  control). 
Quantitative real-time PCR data were analyzed by using the previously de-
scribed 2(Ct) method (Livak and Schmittgen, 2001). All mRNA expression 
levels were calculated by setting the mRNA expression of the control group 
as 100% and individually calculating the  expression for each mRNA sam-
ple. The calculated change in mRNA expression for each noncontrol indi-
vidual was then plotted, and the mean and SEM calculated.
Cell purification and in vitro stimulation. Day 18 placentas were isolated 
from BALB/c mice, and a single-cell suspension of the whole placenta was 
prepared by meshing through a 100-µm filter. Because mice have hemochorial 
placentation in which both the maternal and fetal sides of the placenta are ex-
posed to maternal blood in vivo, all placental cell types were used for the cell 
culture. Primary placental cells were cultured at 5 × 106 cells per well in tripli-
cate with 10 ng/ml IL-6 for 4 h. mRNA was isolated, cDNA was constructed, 
and quantitative real-time PCR was performed for TLR2, 3, 4, 5, 6, 7, and 9.
BMDMs from wild-type, heterozygous TLR2/3/4/7/9+/, and homo-
zygous TLR2/3/4/7/9/ knockout mice were stimulated as indicated for 
8 h (Fig. 2), after which supernatants were tested using ELISA. TLR ligands 
used  were  dipalmitoylated  hexpapeptide  for TLR2  (Pam2CSK4;  EMC 
Microcollections), polyinosinic–polycytidylic acid for TLR3 (Poly I:C; 
Sigma-Aldrich), LPS for TLR4 (ultra-pure Salmonella minnesota Re595; 
Conclusion
Our data provide strong evidence in favor of the hygiene hy-
pothesis and demonstrate how prenatal asthma-protective ef-
fects from maternal microbial treatment are transferred from 
the mother to the progeny. For the first time, a causal relation-
ship between prenatal exposure to stable-derived bacteria, 
functional maternal TLR signaling, and protection against ex-
perimental asthma is described. A. lwoffii F78 acts via the up-
regulation of maternal lung TLR expression in conjunction 
with initiation of a transient acute local Th1-like inflamma-
tory response. This local response is followed by systemic dis-
tribution of inflammatory cytokines and a down-regulation of 
TLR and cytokine expression in the placenta. Furthermore, 
as offspring from A. lwoffii F78–treated TLR2/3/4/7/9/ 
mothers are no longer protected from experimental asthma, 
this strongly indicates that maternal TLR signaling plays a 
pivotal role in the transfer of protective effects. Collectively, 
the results of our study elucidate a novel mechanism for pre-
natal  asthma  protection  and  may  incite  novel  clinical  ap-
proaches for allergy and asthma prevention.
MATERIALS AND METHODS
Animals. 6–8-wk-old female BALB/c and C57BL/6 mice were obtained 
from Harlan Winkelmann. Mice were kept under specific pathogen-free 
housing conditions and were supplied with water and an OVA-free diet ad 
libitum. All animal experiments were performed in accordance with German 
and international guidelines and were approved by local authorities (Regier-
ungspräsidium Gießen).
TLR-knockout mice. Wild-type and TLR2/ (Spiller et al., 2007), TLR3/ 
(Honda et al., 2003), TLR4/ (Hoshino et al., 1999), TLR7/ (Hemmi et al., 
2002), and TLR9/ (Hemmi et al., 2000) mice were backcrossed toward 
the genetic C57BL/6 background at least six times, and were subsequently 
intercrossed to generate TLR2//TLR3//TLR4//TLR7//TLR9/ 
(TLR2/3/4/7/9/) mice. TLR2/3/4/7/9/ mice were healthy under reg-
ular housing conditions and displayed no obvious abnormalities.
Prenatal A. lwoffii F78 exposure. According to protocols previously opti-
mized for microbial concentration and treatment timing (Blümer et al., 2005, 
2007), female mice of the BALB/c, C57BL/6, and C57BL6 TLR2/3/4/7/9/ 
backgrounds received intranasal applications of 108 CFU of freeze-dried 
A. lwoffii F78 reconstituted in a volume of 50 µl PBS 11, 9, 6, 4, and 2 d before 
mating, as well as every other day three times per week during gestation. Age-
matched control animals were sham treated with PBS.
Sensitization, challenge, and treatment of offspring. Offspring from 
A. lwoffii F78– or control-treated mothers were sensitized to OVA at the 
age of 25 and 39 d by intraperitoneal injection of 10 µg OVA (grade VI; 
Sigma-Aldrich) emulsified in 1.5 mg Al(OH)3 (Thermo Fisher Scientific) in 
a total volume of 200 µl. The sham group received PBS with Al(OH)3. At 
days 44, 45, and 46 after birth, animals were exposed to aerosolized OVA 
(1% wt/vol diluted in PBS) for 20 min. Lung function was analyzed 24 h 
(day 47) after the last aerosol challenge, and another 24 h later (day 48), 
mice were terminally anesthetized with ketamine plus rompun for further 
analyses (described in the following paragraphs).
Assessment of offspring airway reactivity. 24 h after the last challenge, 
lung function analysis was performed in conscious animals using noninvasive 
head-out body plethysmography. The midexpiratory airflow (EF50) of bronchial 
responsiveness to MCh was measured as described previously (Neuhaus-
Steinmetz et al., 2000). Airway hyperreactivity is represented in the figures 
by a lower MCh concentration that induces a 50% reduction in baseline 
EF50 (MCh50).JEM VOL. 206, December 21, 2009  2877
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